pentagastrin has been researched along with fce 20700 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dammann, HG; Müller, P; Simon, B | 1 |
| Barbieri, C; Caldara, R; Cantù, A; Carbone, M; Dubini, A; Ferrari, C; Guslandi, M; Masci, E | 1 |
2 trial(s) available for pentagastrin and fce 20700
| Article | Year |
|---|---|
[Effect of FCE 20,700, an effective oral prostaglandin E2 analog on the human gastric mucosa epithelium].
Topics: Administration, Oral; Adult; Aspirin; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Epithelium; Gastric Acid; Gastric Mucosa; Gastroscopy; Humans; Indomethacin; Male; Membrane Potentials; Pentagastrin; Prostaglandins E, Synthetic; Random Allocation | 1986 |
Effects of FCE20700, a new PGE2 derivative, on gastric acid secretion and cytoprotective processes in man.
Topics: Adult; Bicarbonates; Dinoprostone; Double-Blind Method; Gastric Acid; Gastric Juice; Gastric Mucosa; Gastrins; Humans; Intubation, Gastrointestinal; Male; Mucoproteins; Pentagastrin; Peptones; Prostaglandins E, Synthetic | 1987 |